NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/24/2026 15:39
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5.81 mln
Float6.99 mln
Earnings Date08/19/2026
Piotroski F-Score
1
/ 9
Very weak
Beneish M-Score
-3.63
Highly reliable
Relative Strength
15
/ 100
Significantly lagging
Debt / Equity
0.54
Moderate leverage
ROE
-145
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
CollPlant Biotechnologies is an Israeli company that grows human collagen from plants and uses it to develop medical products. Its offerings include tissue fillers, wound care treatments, tendon repair solutions, and 3D-printed breast implants, with operations spanning the US, Canada, Europe, and beyond. The company also supplies collagen-based materials to other researchers and manufacturers working in regenerative medicine, and works alongside partners such as AbbVie and Stratasys to advance its technology.
